drugset / Trial / NCT00616070
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this phase III study is to determine the safety and efficacy of difluprednate in the management of inflammation following ocular surgery.
Timeline
- Start
- 2007-12
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Difluprednate | Small molecule | — | — |
Indications
No indication recorded.